Yun Hao
Overview
Explore the profile of Yun Hao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li L, Hao Y, Dong L, Qiao Z, Yang S, Chen Y, et al.
Technol Cancer Res Treat
. 2025 Mar;
24:15330338251328500.
PMID: 40080898
Breast cancer is one of the leading causes of cancer-related deaths in women worldwide. Circular RNAs (circRNAs), a novel class of endogenous noncoding RNA with a covalently closed continuous loop...
2.
Deng S, Hao Y, Yang L, Yu T, Wang X, Liu H, et al.
Biosens Bioelectron
. 2025 Mar;
278:117339.
PMID: 40073796
Nanozymes possess the advantages of high stability, adjustable catalytic activity and simple preparation processes, which position them as a promising alternative to natural enzymes. In this work, an oxidase-like nanozyme...
3.
Wang L, Hao Y, Wang S, Wei H
Cogn Neurodyn
. 2024 Nov;
18(5):2487-2502.
PMID: 39555278
Estimating a vanishing point (VP) is a core problem for understanding three-dimensional scenes and autonomous navigation. Existing methods are essential to estimating VPs in indoor and urban environments. However, doing...
4.
Litman A, Sauerwald N, Snyder L, Foss-Feig J, Park C, Hao Y, et al.
medRxiv
. 2024 Aug;
PMID: 39185525
Unraveling the phenotypic and genetic complexity of autism is extremely challenging yet critical for understanding the biology, inheritance, trajectory, and clinical manifestations of the many forms of the condition. Here,...
5.
Hao Y, Xie F, Zhou Y, Li C, Zhang X, Shen J, et al.
Trials
. 2024 Jul;
25(1):490.
PMID: 39030637
Background: The high recurrence rate after liver resection emphasizes the urgent need for neoadjuvant therapy in hepatocellular carcinoma (HCC) to enhance the overall prognosis for patients. Immune checkpoint inhibitors, camrelizumab...
6.
Romano J, Truong V, Kumar R, Venkatesan M, Graham B, Hao Y, et al.
J Med Internet Res
. 2024 Apr;
26:e46777.
PMID: 38635981
Background: As global populations age and become susceptible to neurodegenerative illnesses, new therapies for Alzheimer disease (AD) are urgently needed. Existing data resources for drug discovery and repurposing fail to...
7.
Sokolova K, Chen K, Hao Y, Zhou J, Troyanskaya O
Annu Rev Genomics Hum Genet
. 2024 Apr;
25(1):105-122.
PMID: 38594933
Deciphering the regulatory code of gene expression and interpreting the transcriptional effects of genome variation are critical challenges in human genetics. Modern experimental technologies have resulted in an abundance of...
8.
Yu X, Xin Q, Hao Y, Zhang J, Ma T
Front Med (Lausanne)
. 2024 Mar;
10:1327036.
PMID: 38469459
Background: In sepsis patients, kidney damage is among the most dangerous complications, with a high mortality rate. In addition, major adverse kidney events within 30 days (MAKE30) served as a...
9.
Hao Y, Feng Y, Dong Y, Ren Y, Huang J, Ma H, et al.
Chem Biodivers
. 2024 Feb;
21(5):e202302064.
PMID: 38390665
Based on our previous research, a 3D-QSAR model (q=0.51, ONC=5, r=0.982, F=271.887, SEE=0.052) was established to predict the inhibitory effects of triazole Schiff base compounds on Fusarium graminearum, and its...
10.
Zhu Q, Xiong X, Zheng Q, Deng Q, Hao Y, Liu D, et al.
Prostate Cancer Prostatic Dis
. 2024 Feb;
28(1):11-22.
PMID: 38378977
Background: High-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) have been increasingly adopted for localized prostate cancer (PCa) under active surveillance (AS). However, it is unclear which training modality...